Washington · 2025–26 Regular Sessions · Bill

HB 1425: Pharmacogenomic testing

In committee Last action January 12, 2026: By resolution, reintroduced and retained in present status.

Plain-language summary

HB 1425 is a bill introduced in the Washington House on January 20, 2025. According to its official title, it concerns: Requiring coverage of pharmacogenomic testing for psychotropic medications. Primary sponsor: Lauren Davis (D). It lists 11 additional sponsors. Most recent recorded action (January 12, 2026): By resolution, reintroduced and retained in present status.

Sponsors

Primary sponsor: Lauren Davis (Democratic). 11 co-sponsors.